NDATF (NDatalyze) Cash Ratio: 18.69 (As of Feb. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NDatalyze Cash Ratio?

NDatalyze NDATF Cash Ratio is 18.69 as of Feb. 2026, which is 9% above its 10-year median of 17.22.

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. NDatalyze's Cash Ratio for the quarter that ended in Feb. 2026 was 18.69.

NDatalyze has a Cash Ratio of 18.69. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for NDatalyze's Cash Ratio or its related term are showing as below:

NDATF' s Cash Ratio Range Over the Past 10 Years
Min: 2.57   Med: 17.22   Max: 21.79
Current: 18.39

During the past 8 years, NDatalyze's highest Cash Ratio was 21.79. The lowest was 2.57. And the median was 17.22.

NDATF's Cash Ratio is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.58 vs NDATF: 18.39

NDatalyze  (OTCPK:NDATF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


NDatalyze Cash Ratio Related Terms


NDatalyze Cash Ratio Historical Data

* Premium members only.

The historical data trend for NDatalyze's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NDatalyze Cash Ratio Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Cash Ratio
Get a 7-Day Free Trial 19.61 2.57 21.00 21.53 18.69

NDatalyze Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.53 21.18 35.44 20.79 18.69

NDATF vs VEEV, BTSG, TEM: Cash Ratio Comparison

For the Health Information Services subindustry, NDatalyze's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDatalyze Cash Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's Cash Ratio distribution charts can be found below:

* The bar in red indicates where NDatalyze's Cash Ratio falls into.



NDatalyze Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

NDatalyze's Cash Ratio for the fiscal year that ended in Feb. 2026 is calculated as:

Cash Ratio (A: Feb. 2026 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.243/0.013
=18.69

NDatalyze's Cash Ratio for the quarter that ended in Feb. 2026 is calculated as:

Cash Ratio (Q: Feb. 2026 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.243/0.013
=18.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Ratio →
What does a Cash Ratio of 18.69 mean?
NDatalyze (NDATF) has a Cash Ratio of 18.69 as of Feb. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on NDatalyze and its competitors. This is near median its historical median of 17.22. Over the past decade, NDatalyze's Cash Ratio has ranged from 2.57 to 21.79.
Is NDatalyze's Cash Ratio too high?
NDatalyze's current Cash Ratio of 18.69 is near median its 10-year median of 17.22. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 21.79. The Healthcare Providers & Services industry median Cash Ratio is 0.58. NDatalyze's value of 18.69 is 3122.4% above this industry median.
How does NDatalyze's Cash Ratio compare to VEEV and BTSG?
NDatalyze's Cash Ratio of 18.69 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Ratio is 0.58. NDatalyze's value of 18.69 is 3122.4% above this benchmark. Historically, NDatalyze's own Cash Ratio has ranged from 2.57 to 21.79 over the past decade. While the company's 10-year median is 17.22 vs. the industry median of 0.58, NDatalyze has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.58, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NDatalyze's current Cash Ratio of 18.69 is 3122.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on NDatalyze and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current Cash Ratio is 18.69, which is near median its own 10-year median of 17.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
NDatalyze (NDATF) has a current Cash Ratio of 18.69. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current Cash Ratio is 18.69, which is near median its 10-year median of 17.22 and 3122.4% above the Healthcare Providers & Services industry median of 0.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For NDatalyze (NDATF), the current Cash Ratio is 18.69 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NDatalyze Business Description

Other Exchanges NDAT:Canada
Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.